Go offline with the Player FM app!
Why GLP-1 weight loss drugs are catching investor attention
Manage episode 382750782 series 1456832
This week Stanford Brown CEO Vincent O'Neill meets once again with CIO Nick Ryder to discuss:
- The RBA’s widely anticipated rate hike and where to from here?
- Driving factors behind Australia’s higher-than-expected inflation numbers
- Whether geopolitical risks impact portfolio positioning?
- The potential for GLP-1 “wonder drugs” to impact different companies such as Resmed and CSL
Music provided by: Autumn Trumpet Background Corporate by LesFM | https://lesfm.net/ Music promoted by https://www.chosic.com/free-music/all/ Creative Commons CC BY 3.0 https://creativecommons.org/licenses/by/3.0/
108 episodes
Manage episode 382750782 series 1456832
This week Stanford Brown CEO Vincent O'Neill meets once again with CIO Nick Ryder to discuss:
- The RBA’s widely anticipated rate hike and where to from here?
- Driving factors behind Australia’s higher-than-expected inflation numbers
- Whether geopolitical risks impact portfolio positioning?
- The potential for GLP-1 “wonder drugs” to impact different companies such as Resmed and CSL
Music provided by: Autumn Trumpet Background Corporate by LesFM | https://lesfm.net/ Music promoted by https://www.chosic.com/free-music/all/ Creative Commons CC BY 3.0 https://creativecommons.org/licenses/by/3.0/
108 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.